孤立性颈项透明层增厚胎儿中二代测序的诊断率:系统综述与meta分析
ES/GS检出致病或可能致病变异15例,合并增量诊断率为4%(95%CI 2-6%),其中6例NT≥5mm;遗传模式以常染色体显性为主(12例,含4例Noonan综合征)。
要点
- 对NT>99th百分位且无合并异常的胎儿,CMA阴性后ES/GS增量诊断率为4%(95%CI 2-6%)。
- 检出致病变异者中40%(6/15)NT≥5mm,但NT截断值是否应高于3.5mm尚不明确。
- 遗传模式以常染色体显性为主(12/15),其中4例为Noonan综合征。
局限性
- NT截断值高于3.5mm是否更利于ES/GS病例选择尚不明确。
- 仅纳入英文研究,可能存在语言偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the diagnostic yield of exome or genome sequencing (ES/GS) over chromosomal microarray analysis (CMA) in fetuses with increased nuchal translucency (NT) and no concomitant anomalies.
METHODS: This systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria. PubMed, Scopus and Web of Science were searched for studies describing ES/GS in fetuses with isolated increased NT. Inclusion criteria were: (1) study written in English; (2) more than two fetuses with increased NT > 99th percentile and no concomitant anomalies; and (3) a negative CMA result considered as the reference standard. Only positive variants identified on ES/GS that were classified as likely pathogenic or pathogenic and determined to be causative of the fetal phenotype were considered. Risk was assessed as the pooled effect size by single-proportion analysis using random-effects modeling (weighted by inverse of variance).
RESULTS: Eleven studies reporting on the diagnostic yield of ES/GS in fetuses with isolated increased NT > 99th percentile were identified and included 309 cases. All studies were high quality according to Standards for Reporting of Diagnostic Accuracy. Overall, a pathogenic or likely pathogenic variant was identified on ES/GS in 15 fetuses, resulting in a pooled incremental yield of 4% (95% CI, 2-6%). Six (40%) of these fetuses had NT of 5 mm or more. The observed inheritance pattern was autosomal dominant in 12 cases, including four fetuses with Noonan syndrome, autosomal recessive in two cases and X-linked in one case.
CONCLUSIONS: There is a 4% incremental diagnostic yield of ES/GS over CMA in fetuses with increased NT > 99th percentile without a concomitant anomaly. It is unclear whether a NT cut-off higher than 3.5 mm may be more useful in case selection for ES/GS. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Pauta M, Martinez-Portilla RJ, Borrell A, et al. Diagnostic yield of next-generation sequencing in fetuses with isolated increased nuchal translucency: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022. PMID: 34309942. doi:10.1002/uog.23746
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。